Another study (75) demonstrated that miR-302a downregulation confers radioresistance and that restoration of its expression sensitizes breast cancer cells to radiotherapy since miR-302a targets RAD52, an essential participant in HR repair, and AKT1 (76). Here, AKT1 is linked to breast cancer.